Director, TB/HIV Research & Development - TB vaccines/drugs, HIV vaccines, biologics, long-acting drugs @ Bill & Melinda Gates Foundation. Only my own views.
For the first time in a century, a new TB vaccine may be within reach.
On @RootofSciPod, my colleague Professor Lee Fairlie discusses potentially game-changing trials like M72.
🎧 Listen: https://t.co/jA5qYIi0Te
“I’m a believer in human creativity and innovation.”
In advance of HIV Vaccine Awareness Day, I sat down with @AVAC’s #PxPulse to discuss why a vaccine remains essential to ending the epidemic.
What will it take to #EndTB? Continued investment in global health R&D innovation & a continued focus on local community engagement. Read about the local experts, leaders, and advocates I met in Johannesburg who are changing the trajectory of TB 🧵 ⬇️1/6
“The best treatments in the world will not be useful if we cannot find the people who need them” - Dr. Nina Russell, Bill and Melinda Gates Foundation #UnionConf2023 Opening Session
If this doesn’t keep us up at night, nothing will. Challenging to fix an #HIV and a #TB epidemic when basic needs like this fill the space. @PresidencyZA
Today I’m thrilled to share that we’re funding nearly 50 new Grand Challenges grant recipients who are developing global health and development solutions for their communities using AI-enabled LLMs.
You can read more about the selected projects here: https://t.co/BZhl6OKGep
Optimism about new tools to prevent & treat #tuberculosis is growing. Funding the development & equitable delivery of game-changing tools is critical to tackling the world's deadliest infectious disease. @jriggers
Yesterday @wellcometrust & @gatesfoundation announced co-funding for a Phase 3 clinical trial for the M72 TB vaccine candidate
A big & exciting step on a long journey that could lead to the 1st TB vaccine in 100 yrs to add to our TB toolkit
https://t.co/1L380pRqC4
Today, the @GatesFoundation launched a new Grand Challenge — Catalyzing Equitable AI Use — which seeks innovative approaches to the use of LLMs to improve global health and development outcomes.
@AnitaZaidi and I discuss the role that equity and access play when approaching AI:
https://t.co/2jjtjsQ0WM
There is an urgent need for sustained investment in continued collaborative HIV vaccine research and development. Now is NOT the time to back off.
JIAS is marking #HIVVaccineAwarenessDay with a new viewpoint: “Iterative Hypothesis Testing in #HIV Vaccine Research: Moving Toward Success”, in which @NinaRussellMD and Pervin Anklesaria outline the challenges and advances within this research field: https://t.co/IgqbBB5bgg
@jiasociety An effective #HIV vaccine is crucial in reducing HIV incidence in high-burden countries. And exciting new approaches offer hope for a breakthrough.
JIAS is marking #HIVVaccineAwarenessDay with a new viewpoint: “Iterative Hypothesis Testing in #HIV Vaccine Research: Moving Toward Success”, in which @NinaRussellMD and Pervin Anklesaria outline the challenges and advances within this research field: https://t.co/IgqbBB5bgg
Today marks #WorldTBDay.
As @WHOAFRO highlights, it's crucial for African countries to prioritize the below measures to #EndTB across the continent for good:
✅ Investing in preventative measures
✅ Ending #stigma and #discrimination
✅ Ensuring #EqualAccess to health services
#YesWeCanEndTB if we invest in the R&D of new diagnostics, medicines, and vaccines.
On #WorldTBDay, I am joining @StopTB alongside my colleagues @puneetkdewan and Alison to call for increased efforts to #EndTB.
Sustained investments in innovative tools for TB diagnosis, treatment, prevention and delivery are key to progress toward ending TB. https://t.co/PCKDL8BjN2 via @gatesfoundation